Aortic valve replacement and perioperative management in hemodialyzed patient with antiphospholipid syndrome

International Journal of Artificial Organs

Volumn 27, Issue 1, 2004, Pages 69-73

  Lango, Romuald ^a   Pawlaczyk, R ^a   Raszeja Specht, A ^a   Smolenski R T ^a   Rogowski, J ^a   Rutkowski, B ^a   Szutowicz, A ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Anticoagulation; Antiphospholipid syndrome; Aortic valve replacement; Cardio pulmonary bypass; Chronic renal failure

Indexed keywords

BLOOD VESSELS; CARDIOVASCULAR SURGERY; PHOSPHOLIPIDS;

ACTIVATED CLOTTING TIME; ANTI-COAGULATION; ANTIPHOSPHOLIPID SYNDROMES; ANTIPHOSPHOLIPIDS; AORTIC VALVE REPLACEMENT; AORTIC VALVES; CARDIAC-SURGERY; CARDIO-PULMONARY BYPASS; CHRONIC RENAL FAILURE; VALVE REPLACEMENT;

POLYSACCHARIDES;

ACENOCOUMAROL; HEPARIN; NADROPARIN; PHOSPHOLIPID ANTIBODY; PROTAMINE;

ADULT; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CASE REPORT; CHRONIC KIDNEY FAILURE; DRUG BLOOD LEVEL; DRUG SAFETY; HEART SURGERY; HEMODIALYSIS PATIENT; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; PATIENT MONITORING; PERIOPERATIVE PERIOD; THROMBOSIS; TITRIMETRY;

EID: 1442281791     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880402700113     Document Type: Article

References (17)

1. Lockshin MD. Antiphospholipid antibody syndrome. Rheum Dis Clin North Am 1994; 20: 45-59.
2. Roubey RAS. Antibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other "antiphospholipid" auto-antibodies. Blood 1994; 84: 2854-67.
3. Smythe MA, Koerber JM, Nowak SN, Mattison JC, Begle RL, Westley SJ, et al. Correlation between activated clotting time and activated partial thromboplastin times. Ann Pharmacother 2002; 36: 7-11.
4. Bevers EM, Galli M, Barbui T, Comfirus P, Zwaal RFA. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-32.
5. McNeil HP, Simpson RJ, Chesterman CN, Kilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: Beta2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4.
6. Sandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: An update: On behalf of the Subcommittee on Lupus Anticoagulant / Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995; 74: 1185-90.
7. Petri M, Rheinschmidt M, Whiting-O'Keefe Q, Hellmann D, Corash L. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russel viper venom time and anticardiolipin antibody level. Ann Intern Med 1987; 106: 524-31.
8. Ginsberg JS, Demer C, Brill-Edwards P, Bona R, Johnston M, Wong A, et al. Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus. Am J Med 1995; 98: 379-83.
9. Ciocca RG, Choi J, Graham AM. Antiphospholipid antibodies lead to increased risk of cardiovascular surgery. Am J Surg 1995; 170: 198-200.
10. Despotis GJ, Joist JH, Hogne CW Jr, Alsoufier A, Joiner-Maier D, Santoro SA, et al. More effective suppression of hemostasis system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentration rather than ACT. Thromb Haemost 1996; 76: 902-8.
11. Hogan WJ, McBane RD, Santrach PJ, Plumhoff EA, Olivier WC, Schaff HV, et al. Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery. Mayo Clin Proc 2000; 75: 971-6.
12. Levine SR, Deegan MJ, Futrell N, Welch KMA. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990; 40: 1181-9.
13. Sheikh F, Lechowicz A, Setlur R, Rauch A, Dunn H. Recognition and management of patients with antiphospholipid antibody syndrome undergoing cardiac surgery. J Cardiothorac Vasc Anesth 1997; 11: 764-6.
14. Kato Y, Isobe F, Sasaki Y, Kodera K, Kumano H, Nagamachi K Mitral insufficiency associated with primary antiphospholipid syndrome and chronic renal failure. Jpn J Thorac Cardiovasc Surg 2001; 49: 171-4.
15. Kato Y, Isobe F, Sasaki Y, Kumano H, Nagamachi K, Arimoto H. Secondary mitral valve replacement in antiphospholipid syndrome and chronic renal failure. Jpn J Thorac Cardiovasc Surg 2001; 49: 728-31.
16. Saphiro SS, Thiagarajan P. Lupus anticoagulants. Prog Hemost Thromb 1982; 6: 263-85.
17. Bouillanne O, Millaire A, De Groote P, Puisieux P, Cesbron JY, Jude B, et al. Prevalence and clinical significance of antiphospholipid antibodies in heart valve disease: A case-control study. Am Heart J 1996; 132: 790-5.